Thalidomide arm of Total Therapy 2 improves complete remission duration and survival in myeloma patients with metaphase cytogenetic abnormalities (Q36941047)
Jump to navigation
Jump to search
scientific article published on 20 May 2008
Language | Label | Description | Also known as |
---|---|---|---|
English | Thalidomide arm of Total Therapy 2 improves complete remission duration and survival in myeloma patients with metaphase cytogenetic abnormalities |
scientific article published on 20 May 2008 |
Statements
1 reference
Thalidomide arm of Total Therapy 2 improves complete remission duration and survival in myeloma patients with metaphase cytogenetic abnormalities (English)
1 reference
Bart Barlogie
1 reference
Sarah Waheed
1 reference
Elias Anaissie
1 reference
Maurizio Zangari
1 reference
Mauricio Pineda-Roman
1 reference
Jeff Haessler
1 reference
Klaus Hollmig
1 reference
Yazan Alsayed
1 reference
Nathan Petty
1 reference
Joshua Epstein
1 reference
John D Shaughnessy
1 reference
Guido Tricot
1 reference
Jerome Zeldis
1 reference
Sol Barer
1 reference
John Crowley
1 reference
20 May 2008
1 reference
1 reference
3115-3121
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference